Pertussis Acellular Vaccine Component from Japan
Pertussis acellular vaccine component consists of purified antigens such as pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin, used in combination vaccines for prophylaxis. It is a toxin or culture-derived product for prophylactic mixing, classified under tariff item 3002.49.00 as 'Other' vaccines, toxins, or cultures of micro-organisms.
Duty Rate — Japan → Canada
0%
Import Tips
• Ensure the component is imported for use in a licensed vaccine product and has the necessary Health Canada approval
• Declare the product under 3002.49.00 and provide technical documentation on the antigen composition to support classification
• Verify if the product is duty-free under the MFN tariff, but confirm with the CBSA for current rates